🟡 70/100

Review before taking

  • Niacin: 54mg is 1.5× the Tolerable Upper Intake Level (35mg)
  • Contains proprietary blend — exact ingredient amounts not disclosed
  • 50% of ingredients have research evidence
C Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

⚠️ Niacin: 54mg is 1.5× the Tolerable Upper Intake Level (35mg)
ℹ️ Contains proprietary blend — exact ingredient amounts not disclosed

The safety score is low because the niacin content exceeds the recommended daily upper limit and the product uses a proprietary blend that does not disclose the exact amounts of all ingredients.

Label Data

1 Capsule(s) Serving Size
Other Combinations Product Type
50% Evidence Coverage

Supplement Facts — Evidence Check

54 mg (270% DV)
⚠️ Exceeds Tolerable Upper Intake Level by 1.5× (UL: 35 mg) 📚 193 studies (Tier A: 5, B: 63)
RDA 14mg This product: 54mg UL 35mg
Proprietary Blend
3300 mg

Other Ingredients

Gelatin Stearic Acid

Label Claims — Verification

All Other
Structure/Function
All Other (97% of products) Structure/Function (86% of products) Nutrient (36% of products)

Target Groups

Adult Male (18-50 Years)

Product Information

📋 Directions for Use

DIRECTIONS FOR NUTRITIONAL USE: 1-2 capsules up to twice a day for 1-4 months, or as directed. Then, take as needed for maintenance. Increase the amount of liquids you drink each day while taking this product.

⚠️ Warnings & Precautions

Keep away from Heat, Sunlight and Children.

May cause Niacin Flush (A hot tingling effect to the skin that may disappear within 2-3 hours). Arginine may aggravate the herpes complex.

Additional Information

Keep away from Heat, Sunlight and Children.

Helps the male body feel an overall sense of uplifted energy. Enhances vigor, vitality, strength and muscle mass.

SOLD THROUGH PROFESSIONALS

#71 E/11

MADE IN U.S.A.

Product Details

UPC / SKU 6 35585 00711 5
DSLD Entry Date 2013-05-24
Product Type Other Combinations
Form Capsule
DSLD ID 21954
Data Updated 2026-04-11

Research Evidence

241 Research Sources
55 Avg Quality Score
113 Meta Analysis
75 Systematic Review
32 Rct
11 Clinical Trial
3 Other
3 Regulatory Source
1 Cochrane Review
1 Narrative Review
1 Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016
View all evidence for Niacin →

Compare Similar Products

View all Niacin products →